GO:0044212 | transcription regulatory region DNA binding | 1.20e-06 | 1.73e-02 | 5.424 | 4 | 17 | 168 |
GO:0005654 | nucleoplasm | 4.32e-06 | 6.23e-02 | 3.322 | 6 | 64 | 1082 |
GO:0042789 | mRNA transcription from RNA polymerase II promoter | 2.09e-05 | 3.02e-01 | 8.116 | 2 | 2 | 13 |
GO:0008380 | RNA splicing | 2.06e-04 | 1.00e+00 | 4.568 | 3 | 22 | 228 |
GO:0060795 | cell fate commitment involved in formation of primary germ layer | 5.55e-04 | 1.00e+00 | 10.816 | 1 | 1 | 1 |
GO:0023057 | negative regulation of signaling | 5.55e-04 | 1.00e+00 | 10.816 | 1 | 1 | 1 |
GO:2000016 | negative regulation of determination of dorsal identity | 5.55e-04 | 1.00e+00 | 10.816 | 1 | 1 | 1 |
GO:0072376 | protein activation cascade | 5.55e-04 | 1.00e+00 | 10.816 | 1 | 1 | 1 |
GO:0051435 | BH4 domain binding | 5.55e-04 | 1.00e+00 | 10.816 | 1 | 1 | 1 |
GO:0090308 | regulation of methylation-dependent chromatin silencing | 5.55e-04 | 1.00e+00 | 10.816 | 1 | 1 | 1 |
GO:0090081 | regulation of heart induction by regulation of canonical Wnt signaling pathway | 5.55e-04 | 1.00e+00 | 10.816 | 1 | 1 | 1 |
GO:0060965 | negative regulation of gene silencing by miRNA | 5.55e-04 | 1.00e+00 | 10.816 | 1 | 1 | 1 |
GO:0005515 | protein binding | 9.24e-04 | 1.00e+00 | 1.260 | 8 | 198 | 6024 |
GO:0060242 | contact inhibition | 1.11e-03 | 1.00e+00 | 9.816 | 1 | 1 | 2 |
GO:0009786 | regulation of asymmetric cell division | 1.11e-03 | 1.00e+00 | 9.816 | 1 | 1 | 2 |
GO:0044324 | regulation of transcription involved in anterior/posterior axis specification | 1.11e-03 | 1.00e+00 | 9.816 | 1 | 1 | 2 |
GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress | 1.11e-03 | 1.00e+00 | 9.816 | 1 | 1 | 2 |
GO:0044822 | poly(A) RNA binding | 1.57e-03 | 1.00e+00 | 2.772 | 4 | 50 | 1056 |
GO:0030529 | ribonucleoprotein complex | 1.62e-03 | 1.00e+00 | 5.009 | 2 | 5 | 112 |
GO:1902177 | positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway | 1.66e-03 | 1.00e+00 | 9.231 | 1 | 1 | 3 |
GO:0060913 | cardiac cell fate determination | 1.66e-03 | 1.00e+00 | 9.231 | 1 | 1 | 3 |
GO:0003130 | BMP signaling pathway involved in heart induction | 1.66e-03 | 1.00e+00 | 9.231 | 1 | 1 | 3 |
GO:0005634 | nucleus | 1.82e-03 | 1.00e+00 | 1.469 | 7 | 159 | 4559 |
GO:0038127 | ERBB signaling pathway | 2.22e-03 | 1.00e+00 | 8.816 | 1 | 1 | 4 |
GO:0001714 | endodermal cell fate specification | 2.77e-03 | 1.00e+00 | 8.494 | 1 | 1 | 5 |
GO:0043620 | regulation of DNA-templated transcription in response to stress | 2.77e-03 | 1.00e+00 | 8.494 | 1 | 1 | 5 |
GO:0070934 | CRD-mediated mRNA stabilization | 2.77e-03 | 1.00e+00 | 8.494 | 1 | 2 | 5 |
GO:0006974 | cellular response to DNA damage stimulus | 2.93e-03 | 1.00e+00 | 4.578 | 2 | 7 | 151 |
GO:0070937 | CRD-mediated mRNA stability complex | 3.32e-03 | 1.00e+00 | 8.231 | 1 | 3 | 6 |
GO:0042382 | paraspeckles | 3.32e-03 | 1.00e+00 | 8.231 | 1 | 2 | 6 |
GO:0000398 | mRNA splicing, via spliceosome | 3.44e-03 | 1.00e+00 | 4.459 | 2 | 15 | 164 |
GO:0061099 | negative regulation of protein tyrosine kinase activity | 3.88e-03 | 1.00e+00 | 8.009 | 1 | 1 | 7 |
GO:0003714 | transcription corepressor activity | 4.04e-03 | 1.00e+00 | 4.340 | 2 | 11 | 178 |
GO:0042754 | negative regulation of circadian rhythm | 4.43e-03 | 1.00e+00 | 7.816 | 1 | 1 | 8 |
GO:0001955 | blood vessel maturation | 4.43e-03 | 1.00e+00 | 7.816 | 1 | 1 | 8 |
GO:0007172 | signal complex assembly | 4.43e-03 | 1.00e+00 | 7.816 | 1 | 1 | 8 |
GO:0060396 | growth hormone receptor signaling pathway | 4.43e-03 | 1.00e+00 | 7.816 | 1 | 1 | 8 |
GO:0010467 | gene expression | 4.67e-03 | 1.00e+00 | 3.015 | 3 | 45 | 669 |
GO:0006983 | ER overload response | 4.98e-03 | 1.00e+00 | 7.646 | 1 | 1 | 9 |
GO:0031953 | negative regulation of protein autophosphorylation | 4.98e-03 | 1.00e+00 | 7.646 | 1 | 1 | 9 |
GO:0005737 | cytoplasm | 5.35e-03 | 1.00e+00 | 1.522 | 6 | 124 | 3767 |
GO:0035413 | positive regulation of catenin import into nucleus | 5.53e-03 | 1.00e+00 | 7.494 | 1 | 2 | 10 |
GO:0045662 | negative regulation of myoblast differentiation | 6.09e-03 | 1.00e+00 | 7.357 | 1 | 3 | 11 |
GO:0017166 | vinculin binding | 6.09e-03 | 1.00e+00 | 7.357 | 1 | 1 | 11 |
GO:0060391 | positive regulation of SMAD protein import into nucleus | 6.09e-03 | 1.00e+00 | 7.357 | 1 | 4 | 11 |
GO:0000380 | alternative mRNA splicing, via spliceosome | 6.09e-03 | 1.00e+00 | 7.357 | 1 | 2 | 11 |
GO:0035198 | miRNA binding | 6.64e-03 | 1.00e+00 | 7.231 | 1 | 1 | 12 |
GO:0071480 | cellular response to gamma radiation | 7.19e-03 | 1.00e+00 | 7.116 | 1 | 1 | 13 |
GO:0008134 | transcription factor binding | 7.34e-03 | 1.00e+00 | 3.897 | 2 | 18 | 242 |
GO:0034614 | cellular response to reactive oxygen species | 7.74e-03 | 1.00e+00 | 7.009 | 1 | 2 | 14 |
GO:0001824 | blastocyst development | 8.29e-03 | 1.00e+00 | 6.909 | 1 | 2 | 15 |
GO:0000166 | nucleotide binding | 8.37e-03 | 1.00e+00 | 3.799 | 2 | 13 | 259 |
GO:0043274 | phospholipase binding | 8.84e-03 | 1.00e+00 | 6.816 | 1 | 1 | 16 |
GO:0032757 | positive regulation of interleukin-8 production | 1.10e-02 | 1.00e+00 | 6.494 | 1 | 1 | 20 |
GO:0048041 | focal adhesion assembly | 1.16e-02 | 1.00e+00 | 6.424 | 1 | 1 | 21 |
GO:0070932 | histone H3 deacetylation | 1.16e-02 | 1.00e+00 | 6.424 | 1 | 2 | 21 |
GO:0036464 | cytoplasmic ribonucleoprotein granule | 1.21e-02 | 1.00e+00 | 6.357 | 1 | 2 | 22 |
GO:0019901 | protein kinase binding | 1.24e-02 | 1.00e+00 | 3.508 | 2 | 18 | 317 |
GO:0070059 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress | 1.27e-02 | 1.00e+00 | 6.293 | 1 | 1 | 23 |
GO:0008283 | cell proliferation | 1.32e-02 | 1.00e+00 | 3.459 | 2 | 14 | 328 |
GO:0006355 | regulation of transcription, DNA-templated | 1.42e-02 | 1.00e+00 | 2.440 | 3 | 43 | 997 |
GO:0035329 | hippo signaling | 1.43e-02 | 1.00e+00 | 6.116 | 1 | 5 | 26 |
GO:0051209 | release of sequestered calcium ion into cytosol | 1.43e-02 | 1.00e+00 | 6.116 | 1 | 1 | 26 |
GO:0003723 | RNA binding | 1.43e-02 | 1.00e+00 | 3.398 | 2 | 18 | 342 |
GO:0000976 | transcription regulatory region sequence-specific DNA binding | 1.43e-02 | 1.00e+00 | 6.116 | 1 | 3 | 26 |
GO:0043565 | sequence-specific DNA binding | 1.46e-02 | 1.00e+00 | 3.381 | 2 | 11 | 346 |
GO:0048754 | branching morphogenesis of an epithelial tube | 1.49e-02 | 1.00e+00 | 6.061 | 1 | 1 | 27 |
GO:0005875 | microtubule associated complex | 1.54e-02 | 1.00e+00 | 6.009 | 1 | 1 | 28 |
GO:0030032 | lamellipodium assembly | 1.60e-02 | 1.00e+00 | 5.958 | 1 | 1 | 29 |
GO:0042594 | response to starvation | 1.71e-02 | 1.00e+00 | 5.862 | 1 | 4 | 31 |
GO:1903507 | negative regulation of nucleic acid-templated transcription | 1.76e-02 | 1.00e+00 | 5.816 | 1 | 2 | 32 |
GO:0034446 | substrate adhesion-dependent cell spreading | 1.98e-02 | 1.00e+00 | 5.646 | 1 | 2 | 36 |
GO:0042752 | regulation of circadian rhythm | 2.03e-02 | 1.00e+00 | 5.607 | 1 | 3 | 37 |
GO:0045892 | negative regulation of transcription, DNA-templated | 2.04e-02 | 1.00e+00 | 3.126 | 2 | 24 | 413 |
GO:0006366 | transcription from RNA polymerase II promoter | 2.10e-02 | 1.00e+00 | 3.105 | 2 | 30 | 419 |
GO:0035019 | somatic stem cell maintenance | 2.20e-02 | 1.00e+00 | 5.494 | 1 | 6 | 40 |
GO:0031124 | mRNA 3'-end processing | 2.31e-02 | 1.00e+00 | 5.424 | 1 | 2 | 42 |
GO:0003677 | DNA binding | 2.44e-02 | 1.00e+00 | 2.151 | 3 | 49 | 1218 |
GO:0001047 | core promoter binding | 2.47e-02 | 1.00e+00 | 5.324 | 1 | 5 | 45 |
GO:0006369 | termination of RNA polymerase II transcription | 2.47e-02 | 1.00e+00 | 5.324 | 1 | 2 | 45 |
GO:0048511 | rhythmic process | 2.47e-02 | 1.00e+00 | 5.324 | 1 | 4 | 45 |
GO:0043525 | positive regulation of neuron apoptotic process | 2.52e-02 | 1.00e+00 | 5.293 | 1 | 4 | 46 |
GO:0006986 | response to unfolded protein | 2.74e-02 | 1.00e+00 | 5.172 | 1 | 4 | 50 |
GO:0034976 | response to endoplasmic reticulum stress | 2.79e-02 | 1.00e+00 | 5.144 | 1 | 2 | 51 |
GO:0045454 | cell redox homeostasis | 2.79e-02 | 1.00e+00 | 5.144 | 1 | 1 | 51 |
GO:0051028 | mRNA transport | 2.85e-02 | 1.00e+00 | 5.116 | 1 | 4 | 52 |
GO:0009611 | response to wounding | 2.85e-02 | 1.00e+00 | 5.116 | 1 | 5 | 52 |
GO:0001725 | stress fiber | 3.01e-02 | 1.00e+00 | 5.035 | 1 | 4 | 55 |
GO:0005643 | nuclear pore | 3.12e-02 | 1.00e+00 | 4.983 | 1 | 11 | 57 |
GO:0006396 | RNA processing | 3.23e-02 | 1.00e+00 | 4.933 | 1 | 5 | 59 |
GO:0043433 | negative regulation of sequence-specific DNA binding transcription factor activity | 3.23e-02 | 1.00e+00 | 4.933 | 1 | 6 | 59 |
GO:0008013 | beta-catenin binding | 3.28e-02 | 1.00e+00 | 4.909 | 1 | 9 | 60 |
GO:0006406 | mRNA export from nucleus | 3.33e-02 | 1.00e+00 | 4.885 | 1 | 4 | 61 |
GO:0006987 | activation of signaling protein activity involved in unfolded protein response | 3.33e-02 | 1.00e+00 | 4.885 | 1 | 2 | 61 |
GO:0019903 | protein phosphatase binding | 3.39e-02 | 1.00e+00 | 4.862 | 1 | 2 | 62 |
GO:0006310 | DNA recombination | 3.55e-02 | 1.00e+00 | 4.794 | 1 | 7 | 65 |
GO:0010468 | regulation of gene expression | 3.71e-02 | 1.00e+00 | 4.729 | 1 | 2 | 68 |
GO:0034329 | cell junction assembly | 3.71e-02 | 1.00e+00 | 4.729 | 1 | 3 | 68 |
GO:0042826 | histone deacetylase binding | 3.93e-02 | 1.00e+00 | 4.646 | 1 | 4 | 72 |
GO:0000785 | chromatin | 3.98e-02 | 1.00e+00 | 4.626 | 1 | 6 | 73 |
GO:0000981 | sequence-specific DNA binding RNA polymerase II transcription factor activity | 4.03e-02 | 1.00e+00 | 4.607 | 1 | 4 | 74 |
GO:0043161 | proteasome-mediated ubiquitin-dependent protein catabolic process | 4.09e-02 | 1.00e+00 | 4.587 | 1 | 1 | 75 |
GO:0071013 | catalytic step 2 spliceosome | 4.25e-02 | 1.00e+00 | 4.531 | 1 | 7 | 78 |
GO:0007229 | integrin-mediated signaling pathway | 4.25e-02 | 1.00e+00 | 4.531 | 1 | 3 | 78 |
GO:0030968 | endoplasmic reticulum unfolded protein response | 4.30e-02 | 1.00e+00 | 4.512 | 1 | 2 | 79 |
GO:0009653 | anatomical structure morphogenesis | 4.51e-02 | 1.00e+00 | 4.441 | 1 | 2 | 83 |
GO:0090090 | negative regulation of canonical Wnt signaling pathway | 4.67e-02 | 1.00e+00 | 4.390 | 1 | 8 | 86 |
GO:0006936 | muscle contraction | 4.73e-02 | 1.00e+00 | 4.373 | 1 | 3 | 87 |
GO:0000187 | activation of MAPK activity | 4.89e-02 | 1.00e+00 | 4.324 | 1 | 3 | 90 |
GO:0007010 | cytoskeleton organization | 4.94e-02 | 1.00e+00 | 4.308 | 1 | 4 | 91 |
GO:0016363 | nuclear matrix | 4.94e-02 | 1.00e+00 | 4.308 | 1 | 6 | 91 |
GO:0006928 | cellular component movement | 4.94e-02 | 1.00e+00 | 4.308 | 1 | 3 | 91 |
GO:0001649 | osteoblast differentiation | 4.99e-02 | 1.00e+00 | 4.293 | 1 | 5 | 92 |
GO:0005770 | late endosome | 5.04e-02 | 1.00e+00 | 4.277 | 1 | 2 | 93 |
GO:0005178 | integrin binding | 5.20e-02 | 1.00e+00 | 4.231 | 1 | 4 | 96 |
GO:0003700 | sequence-specific DNA binding transcription factor activity | 5.41e-02 | 1.00e+00 | 2.367 | 2 | 39 | 699 |
GO:0008360 | regulation of cell shape | 5.57e-02 | 1.00e+00 | 4.130 | 1 | 4 | 103 |
GO:0005938 | cell cortex | 5.63e-02 | 1.00e+00 | 4.116 | 1 | 5 | 104 |
GO:0007050 | cell cycle arrest | 6.68e-02 | 1.00e+00 | 3.862 | 1 | 5 | 124 |
GO:0045944 | positive regulation of transcription from RNA polymerase II promoter | 6.72e-02 | 1.00e+00 | 2.192 | 2 | 41 | 789 |
GO:0030027 | lamellipodium | 6.73e-02 | 1.00e+00 | 3.850 | 1 | 7 | 125 |
GO:0007179 | transforming growth factor beta receptor signaling pathway | 6.88e-02 | 1.00e+00 | 3.816 | 1 | 11 | 128 |
GO:0018108 | peptidyl-tyrosine phosphorylation | 7.09e-02 | 1.00e+00 | 3.772 | 1 | 4 | 132 |
GO:0016055 | Wnt signaling pathway | 7.40e-02 | 1.00e+00 | 3.708 | 1 | 4 | 138 |
GO:0006397 | mRNA processing | 8.54e-02 | 1.00e+00 | 3.494 | 1 | 10 | 160 |
GO:0016607 | nuclear speck | 9.15e-02 | 1.00e+00 | 3.390 | 1 | 12 | 172 |
GO:0005667 | transcription factor complex | 9.31e-02 | 1.00e+00 | 3.365 | 1 | 17 | 175 |
GO:0031625 | ubiquitin protein ligase binding | 9.46e-02 | 1.00e+00 | 3.340 | 1 | 5 | 178 |
GO:0006367 | transcription initiation from RNA polymerase II promoter | 9.76e-02 | 1.00e+00 | 3.293 | 1 | 22 | 184 |
GO:0007173 | epidermal growth factor receptor signaling pathway | 1.00e-01 | 1.00e+00 | 3.254 | 1 | 5 | 189 |
GO:0003713 | transcription coactivator activity | 1.24e-01 | 1.00e+00 | 2.927 | 1 | 24 | 237 |
GO:0006281 | DNA repair | 1.36e-01 | 1.00e+00 | 2.788 | 1 | 14 | 261 |
GO:0005829 | cytosol | 1.47e-01 | 1.00e+00 | 1.116 | 3 | 86 | 2496 |
GO:0005856 | cytoskeleton | 1.50e-01 | 1.00e+00 | 2.631 | 1 | 9 | 291 |
GO:0015031 | protein transport | 1.74e-01 | 1.00e+00 | 2.402 | 1 | 11 | 341 |
GO:0005925 | focal adhesion | 1.86e-01 | 1.00e+00 | 2.300 | 1 | 9 | 366 |
GO:0007155 | cell adhesion | 1.87e-01 | 1.00e+00 | 2.289 | 1 | 5 | 369 |
GO:0046982 | protein heterodimerization activity | 1.92e-01 | 1.00e+00 | 2.246 | 1 | 8 | 380 |
GO:0009986 | cell surface | 2.02e-01 | 1.00e+00 | 2.165 | 1 | 9 | 402 |
GO:0044267 | cellular protein metabolic process | 2.35e-01 | 1.00e+00 | 1.927 | 1 | 20 | 474 |
GO:0045893 | positive regulation of transcription, DNA-templated | 2.36e-01 | 1.00e+00 | 1.915 | 1 | 24 | 478 |
GO:0016020 | membrane | 2.37e-01 | 1.00e+00 | 1.101 | 2 | 46 | 1681 |
GO:0048471 | perinuclear region of cytoplasm | 2.47e-01 | 1.00e+00 | 1.845 | 1 | 8 | 502 |
GO:0000122 | negative regulation of transcription from RNA polymerase II promoter | 2.76e-01 | 1.00e+00 | 1.661 | 1 | 37 | 570 |
GO:0007165 | signal transduction | 4.05e-01 | 1.00e+00 | 0.991 | 1 | 13 | 907 |
GO:0008270 | zinc ion binding | 4.36e-01 | 1.00e+00 | 0.855 | 1 | 27 | 997 |
GO:0005524 | ATP binding | 5.30e-01 | 1.00e+00 | 0.474 | 1 | 31 | 1298 |
GO:0006351 | transcription, DNA-templated | 5.71e-01 | 1.00e+00 | 0.318 | 1 | 57 | 1446 |
GO:0005730 | nucleolus | 6.20e-01 | 1.00e+00 | 0.136 | 1 | 66 | 1641 |
GO:0070062 | extracellular vesicular exosome | 7.67e-01 | 1.00e+00 | -0.413 | 1 | 57 | 2400 |
GO:0005886 | plasma membrane | 7.94e-01 | 1.00e+00 | -0.518 | 1 | 49 | 2582 |